Geliang Gan

Geliang Gan

Auto-generated profile, based on publicly available information

Geliang Gan

Yale Center for Analytical Sciences, New Haven, Connecticut, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2019 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
KIKazunori Inoue
Kazunori Inoue
GGGeliang Gan
Geliang Gan
MCMaria Ciarleglio
Maria Ciarleglio
YZYan Zhang
Yan Zhang
XTXuefei Tian
Xuefei Tian
SIShuta Ishibe
Shuta Ishibe
We identified 2 genes, histone deacetylase 1 (HDAC1) and HDAC2, contributing to the pathogenesis of proteinuric kidney diseases, the leading cause of end-stage kidney disease. mRNA expression profiling from proteinuric mouse glomeruli was linked to Connectivity Map databases, identifying HDAC1 and HDAC2 with the differentially expressed gene set reversible by HDAC inhibitors. In numerous progressive glomerular disease models, treatment with valproic acid (a class I HDAC inhibitor) or SAHA (a pan-HDAC inhibitor) mitigated the degree of proteinuria and glomerulosclerosis, leading to a striking increase in survival. Podocyte HDAC1 and HDAC2 activities were increased in mice podocytopathy models, and podocyte-associated Hdac1 and Hdac2 genetic ablation improved proteinuria and glomerulosclerosis. Podocyte early growth response 1 (EGR1) was increased in proteinuric patients and mice in an HDAC1- and HDAC2-dependent manner. Loss of EGR1 in mice reduced proteinuria and glomerulosclerosis. Longitudinal analysis of the multicenter Veterans Aging Cohort Study demonstrated a 30% reduction in mean annual loss of estimated glomerular filtration rate, and this effect was more pronounced in proteinuric patients receiving valproic acid. These results strongly suggest that inhibition of HDAC1 and HDAC2 activities may suppress the progression of human proteinuric kidney diseases through the regulation of EGR1.

20 September 2018 in AIDS Care
Verified
Journal Article
Closed access
JNJustin S. Nichols
Justin S. Nichols
TKTassos Kyriakides
Tassos Kyriakides
SASampson Antwi
Sampson Antwi
LRLorna Renner
Lorna Renner
MLMargaret Lartey
Margaret Lartey
OTon Behalf of the Sankofa Study Team
on Behalf of the Sankofa Study Team
Adherence to antiretroviral therapy (ART) remains one of the greatest obstacles in pediatric HIV care. We sought to determine the prevalence of adherence to ART among undisclosed HIV-infected children and adolescents in Ghana. We analyzed baseline data from HIV-infected children and adolescents aged 7–18 years old enrolled in the SANKOFA Pediatric HIV disclosure intervention study in Ghana. Antiretroviral medication adherence was measured using caregiver 3-day recall; child 3-day recall; and pharmacy records for antiretroviral time-to-refill. Four hundred and twenty child-caregiver dyads were enrolled from January 2013 to June 2016. The median adherence (interquartile range), as measured by time-to-refill, was 93.2% (68.0%–100.0%). However, only 47.5% of children had ≥95% adherence (“good adherence”) using time-to-refill data. Children of caregivers who had received secondary or higher level of education versus no school (aOR, 2.90, 95% Confidence Interval, CI 1.29–6.56), p = 0.010) or elementary education only (aOR, 2.20, CI, 1.24–3.88, p = 0.007) were more likely to have “good adherence” (≥95%). In this cohort of children unaware of their HIV positive status, median ART adherence rate was sub-optimal (by World Health Organization definition) while 38% had poor adherence (<85%).

2 December 2020 in Clinical Lung Cancer
Verified
Journal Article
Closed access
KHKristen Hysell
Kristen Hysell
RYRamsey Yusuf
Ramsey Yusuf
LBLydia Barakat
Lydia Barakat
MVMichael D Virata
Michael D Virata
GGGeliang Gan
Geliang Gan
BEBrinda Emu
Brinda Emu

25 October 2018 in AIDS Care
Verified
Journal Article
Closed access
AOAngela Ofori-Atta
Angela Ofori-Atta
NRNancy Raynolds
Nancy Raynolds
SASampson Antwi
Sampson Antwi
LRLorna Renner
Lorna Renner
JNJustin S. Nichols
Justin S. Nichols
OTon Behalf of the Sankofa Study Team
on Behalf of the Sankofa Study Team
Prior studies show an association between caregiver depression and child health outcomes. There has been little examination of depression among caregivers of HIV-infected children in sub-Saharan countries where pediatric HIV is concentrated. Using baseline data collected in the pediatric HIV disclosure intervention trial, Sankofa, we examined the prevalence and factors associated with depression among caregivers (N = 446) of children infected with HIV in Ghana. Data were analyzed with descriptive and regression analyses. The mean age of the caregivers was 42.2 ± 10.4 years. Eighty percent of the caregivers were female and 59% were HIV-infected. Twenty-eight percent (n = 126) of the caregivers were found to have mild to severe depression. In the adjusted model, factors significantly associated with caregiver depression included: HIV-positive caregiver status (P = 0.04), low income (P = 0.02), lower social support, (P = 0.01), lower HIV knowledge, (P = 0.01), worse HIV illness perceptions (P≤0.001), and greater perceived HIV stigma (P≤0.001). Although we found a high prevalence of depression among our study participants, several of the risks factors identified are modifiable and amenable to interventions that are locally available and affordable. Trial registration: Uniform Trial Number identifier: NCT01701635.

1 December 2021 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
THThomas Holowka
Thomas Holowka
HCHarry Cheung
Harry Cheung
MMMaricar Malinis
Maricar Malinis
GGGeliang Gan
Geliang Gan
YDYanhong Deng
Yanhong Deng
Marwan M. AzarMarwan M. Azar
Marwan M. Azar

27 June 2022 in Transplant Infectious Disease
Verified
Journal Article
Closed access
MTMollie Tucker
Mollie Tucker
Marwan M. AzarMarwan M. Azar
Marwan M. Azar
ECElizabeth Cohen
Elizabeth Cohen
GGGeliang Gan
Geliang Gan
YDYanhong Deng
Yanhong Deng
MMMaricar Malinis
Maricar Malinis